Nancy Van Damme
Papers
9
Total Citations
93
H-Index
6
About
Dr. Nancy Van Damme is a leading urologic oncologist whose research centers on improving outcomes for prostate cancer patients undergoing robot-assisted radical prostatectomy (RARP). Her major contributions include developing and validating predictive tools that personalize patient care—most notably a novel nomogram to forecast 12-month continence status after surgery, enabling surgeons to counsel patients on individualized incontinence risk. She has also created externally validated nomograms to predict adverse pathological features and lymph node invasion, helping guide treatment decisions. Her work, drawing on prospective multi-institutional Belgian cohorts, has garnered over 100 citations, with her most cited paper (28 citations) offering a practical tool for functional recovery. Dr. Van Damme has investigated practice patterns and quality of care in both prostate and uterine cancers, revealing how institutional factors like on-site radiotherapy availability influence adjuvant treatment decisions. Her studies on high-risk prostate cancer and functional outcomes further underscore her commitment to balancing oncologic control with quality of life. Through nationwide database analyses, she has illuminated stage migration trends and Gleason score concordance, advancing evidence-based surgical oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9